series-a
Stage
1
Investors
About
IBI-Ag develops and manufactures selective biological insecticides for agriculture using antibody- and protein-based biotechnologies to control pests with minimal environmental and health impact. The company has also developed an AI-driven de novo protein design platform for creating novel bioinsecticide proteins.
Explore IBI-Ag's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.